the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Pharmaceutical Market Research

<< Previous Page:   1   2   3   4   5   6   7   8   9   10   11   12   Next >>
 
Analgesics in Denmark
Table of Contents Published: 2009/10 Published by: Euromonitor International
This report presents Analgesics in Denmark. ...

Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Table of Contents Published: 2009/10 Published by: BioSeeker Group AB
This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extensively analyses 133 identified targets of protein kinase dr ...

Innovations in Oncology Diagnostics: Technological advances, growth opportunities and future market outlook
Table of Contents Published: 2009/10 Published by: Business Insights
Despite public policy measures to prevent cancer, such as tobacco control and vaccination against HPV, cancer is sure to remain a significant public health problem throughout the 21st century. Indeed, the global demographic shift towards an ageing populat ...

GlaxoSmithKline plc: PharmaVitae Profile
Table of Contents Published: 2009/10 Published by: Datamonitor
This analysis examines the historical and forecast performance for GSK in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales ...

Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion
Table of Contents Published: 2009/10 Published by: Datamonitor
In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is the most rapid. However, the commerci ...

Emerging Markets Series: Indonesia and Philippines
Table of Contents Published: 2009/10 Published by: Datamonitor
As the developed markets are becoming increasingly mature, Pharma is turning to the emerging markets, where long-term growth can be sustained. Of particular interest are Indonesia and the Philippines, which are currently going through major reforms to exp ...

Market Access, Pricing, and Reimbursement News in the Third Quarter of 2009
Table of Contents Published: 2009/10 Published by: Decision Resources, Inc.
The third quarter of 2009 saw a heated debate in the United States over healthcare reform, the publication of a report on a European investigation of the pharmaceutical industry, the election of new governments in Japan and Germany, and new initiatives by ...

Systemic Fungal Infection Therapeutics Market - South Korea
Table of Contents Published: 2009/10 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ...

Systemic Fungal Infection Therapeutics Market Research - Philippines
Table of Contents Published: 2009/10 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ...

Systemic Fungal Infection Therapeutics Market - Hong Kong
Table of Contents Published: 2009/10 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ...

Worldwide WLAN 2Q09 Market Share Update: Market Stabilizes as Economic and 802.11n Fears Dissipate
Table of Contents Published: 2009/10 Published by: IDC
This IDC update reviews 2Q09 end-user revenue in the wireless LAN (WLAN) infrastructure market (excluding WLAN NICs) and shows the quarter-over-quarter (q/q) and year-over-year (y/y) changes. ...

Systemic Fungal Infection Therapeutics Research - Malaysia
Table of Contents Published: 2009/10 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ...

Pipeline Insight: Disease Modification in Rheumatoid Arthritis - New drug targets compete in crowded market
Table of Contents Published: 2009/10 Published by: Datamonitor
Drugs with new mechanisms, in particular Pfizer' s oral JAK inhibitor CP-690,550 and Chugai/Roche' s Actemra (tocilizumab), will launch for rheumatoid arthritis and should offer advantages over current therapies, but do not come without some safety signal ...

Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes
Table of Contents Published: 2009/10 Published by: Datamonitor
Datamonitor expects the Australian antidiabetics market to reach $416m by 2018. The growth will be driven by the launch of new drug classes, notably the incretin mimetics, and large growth in patient numbers. Although strongest growth is expected in the n ...

Transfection Life Science Dashboard Series 2
Table of Contents Published: 2009/10 Published by: Percepta Associates Inc.
The ability to transfect DNA into mammalian cells and cell lines is a critical step in the analysis of gene expression, protein structure and function and molecular interactions within the cell. The Transfection Dashboard Series Two was developed from res ...

Pipeline Insight: Colorectal Cancer - Growing trend towards personalized medicine
Table of Contents Published: 2009/10 Published by: Datamonitor
CRC incidence will be over 490,000 cases by 2018 in the seven major markets. This large patient base will translate into a high commercial potential for the development of novel, more effective therapies. Currently, there are 77 agents in development for ...

The Market Outlook for Research Products in FY2010
Table of Contents Published: 2009/10 Published by: BioInformatics, LLC
The Market Outlook for Research Products in FY2010 compares and contrasts FY2009 (actual) and FY2010 projected) budgets - in total, and by product category with a special focus on market segment and regional differences. In this report, European and U.S. ...

Pharmaceutical Mergers and Acquisitions
Table of Contents Published: 2009/10 Published by: Cutting Edge Information
Pharmaceutical Mergers and Acquisitions guides you to build an M&A plan that focuses on key goals, avoids costly mistakes, and realizes deal potential as quickly as possible. CEI designed this study to identify the primary drivers of M&A activity. Through ...

Contract Pharmaceutical Manufacturing, Research and Packaging
Table of Contents Published: 2009/10 Published by: BCC Research
This report explores present and future strategies within the contract manufacturing, research, and packaging pharmaceuticals industry. The needs, services offered, criteria for selection, and the advantages of outsourcing are discussed. The study also in ...

Global Skin Cancer Therapeutics Markets
Table of Contents Published: 2009/10 Published by: Frost & Sullivan
This research service analyses the global skin cancer therapeutics market. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts and pipeline analysis has been discussed. It also provides strategic recomme ...

Biosimilars: Beyond the first product wave
Table of Contents Published: 2009/10 Published by: Espicom Business Intelligence
The future of the pharmaceutical industry lies with biotechnology. Biotech drugs account for around 10-15% of the current pharmaceutical market, and the sector is outperforming the market as a whole in terms of growth. ...

Competitor Analysis: Coagulation Factors
Table of Contents Published: 2009/10 Published by: La Merie
The present Competitive Intelligence Report about Coagulation Factors provides a competitor evaluation in the field of plasma-derived and recombinant coagulation factors for topical or systemic administration to treat hereditary or acquired coagulation di ...

World Market for Addiction Disorders, 2009 - 2016, The Future Therapies for Substance Dependence and Impulse Control
Table of Contents Published: 2009/10 Published by: Urch Publishing, Ltd.
The substance dependence field is transforming into a high-growth market opportunity. Supported by the success of Pfizer' s recently launched Chantix/Champix, which is on track for blockbuster status in the smoking cessation sector, pharmacotherapies in d ...

South African Advanced Wound Care Market
Table of Contents Published: 2009/10 Published by: Frost & Sullivan
Advanced wound care in South Africa is typified by four key segments; moist wound care, antimicrobial wound care, negative pressure wound therapy, and advanced therapies. Lucrative growth was experienced in the market in 2008 particularly from the public ...

Malaria Patent Landscape 2009
Table of Contents Published: 2009/10 Published by: France Innovation Scientifique et Transfert (FIST SA)
Malaria, along with HIV and Tuberculosis, is one of the three most common infectious diseases in the world. It has infected human beings for over 50,000 years and may have been a human pathogen throughout the entire history of our species. An estimated 30 ...

HIV Therapy Patent Landscape 2009
Table of Contents Published: 2009/10 Published by: France Innovation Scientifique et Transfert (FIST SA)
The Human Immunodeficiency Virus (HIV) is a double-stranded RNA virus from the Retroviridae family. Discovered in 1983, HIV is responsible for the Acquired Immune Deficiency Syndrome (AIDS). Its mechanisms of action and transmission were described in the ...

Biomarker and Diagnostic Opportunities in Clinical Research for Neurological Diseases
Table of Contents Published: 2009/10 Published by: Decision Resources, Inc.
Biomarkers and imaging tools are enabling technologies in today' s clinical research efforts for neurological diseases. Whether to improve upon existing methods for monitoring disease progression or to discover validated measures to detect diseases earlie ...

SPECIAL REPORT: The Pandemic Paradigm: Balancing Commercial Opportunities with Public Health Concerns in the Face of A/H1N1 2009
Table of Contents Published: 2009/10 Published by: Decision Resources, Inc.
WHO and the European Centre for Disease Prevention and Control (ECDC) are advising countries to prepare for a more severe second wave of A/H1N1 2009 in the winter of 2009-2010. This advisement could be warranted, given that no infectious disease has kille ...

Stroke: Treatments and Prescribing Practices - A Global Survey 2009
Table of Contents Published: 2009/10 Published by: BioPharm Reports (Technology and Markets Ltd)
This report presents the findings of a global survey on current treatments and prescribing practices for Ischaemic Stroke, Haemorrhagic Stroke and Transient Ischaemic Attack (TIA). These findings were made following the participation of more than 230 clin ...

Regenerative Medicines: Bone and Joint Applications
Table of Contents Published: 2009/10 Published by: BCC Research
This report provides a comprehensive overview of the global market for regenerative medicines for bone and joint applications. ...

Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide blockbuster potential
Table of Contents Published: 2009/10 Published by: Datamonitor
In 2008, seven major market sales of anticonvulsants reached $13.6 billion, making it one of the largest therapeutic drug classes in the Pharmaceutical sector. However, generic incursion of second generation anticonvulsants will continue to increase the b ...

Stakeholder Insight: Acute Leukemias - Reaching the limits of cytotoxic chemotherapy
Table of Contents Published: 2009/10 Published by: Datamonitor
The drug therapy of acute myeloid leukemia (AML) and adult acute lymphoblastic leukemia (ALL) is largely based on chemotherapy regimens that have changed little in the past few decades. Patient outcomes for both diseases remain poor, particularly for elde ...

Commercial Insight: Parkinson's Disease - Japan and Europe to drive total market growth
Table of Contents Published: 2009/10 Published by: Datamonitor
The Parkinson' s disease market is approaching maturity, with the threat of generic incursion evident in each drug class. Although growth will be stifled by generic launches, relatively successful lifecycle management strategies and new product launches s ...

Commercial Insight: Antidepressants - Novel mechanism offers hope in depressed market
Table of Contents Published: 2009/10 Published by: Datamonitor
With current blockbuster brands facing generic competition, Datamonitor forecasts the antidepressant market to decline at a compound annual growth rate of -2.0% (20082018). However, an antidepressant with a novel mechanism of action has huge commercial po ...

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Table of Contents Published: 2009/10 Published by: Kalorama Information
The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they once were. But the effectiveness of many antibiotics is ...

The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets
Table of Contents Published: 2009/10 Published by: Kalorama Information
Utilization of wellness programs in the United States has experienced strong recent growth this is expected to continue through the forecast period. As more people participate in wellness programs, their usage of various health care products and services ...

Immunotherapies and Vaccines for Nontraditional Indications
Table of Contents Published: 2009/10 Published by: Insight Pharma Reports
This report: Covers a wide range of conditions for which immunotherapies may be effective, including Alzheimer' s disease, addiction, other neurological indications, cardiovascular diseases, hematological disorders, ophthalmic diseases, bone metabolism di ...

Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Table of Contents Published: 2009/10 Published by: Datamonitor
The life sciences industry is unique and complex. Without having the proper background, it can be difficult for IT vendors to enter this conservative market. Those willing to put in the extra effort to truly understand the pharmaceutical and biotechnology ...

Commercial Insight: Hormonal Contraceptives - Look beyond oral contraception for a competitive edge
Table of Contents Published: 2009/10 Published by: Datamonitor
Since the 1960s, hormonal contraceptives have been widely used as effective birth control in the developed world. Although they are mainly used to prevent pregnancies, they can be used for treating other conditions such as acne, endometriosis, and polycys ...

Orphan Drug Strategies
Table of Contents Published: 2009/10 Published by: Datamonitor
With the pharmaceutical industry reducing its focus on the primary care blockbuster model, Big Pharma is now looking towards the development and commercialization of more niche, high value, often biologic therapies, for the treatment of smaller patient po ...

Pipeline Insight: HIV - The Age of Convenience
Table of Contents Published: 2009/10 Published by: Datamonitor
Three new partnerships are reshaping the competitive environment in HIV. Most notably, Tibotec/Johnson & Johnson is linking up with Gilead to combine their Phase III drug rilpivirine with Truvada to create a new gold standard fixed dose combination for tr ...

Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile
Table of Contents Published: 2009/10 Published by: Datamonitor
This analysis examines the historical and forecast performance for Chugai in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ...

Allergan Inc.: PharmaVitae Profile
Table of Contents Published: 2009/10 Published by: Datamonitor
This analysis examines the historical and forecast performance for Allergan in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fore ...

Alternative Medicine
Table of Contents Published: 2009/10 Published by: Global Industry Analysts, Inc.
The global outlook series on Alternative Medicine provides anecdotes, market briefs, and concise summaries of research findings. The report highlights the primary growth drivers, market challenges, and reviews global and regional trends across various seg ...

Partnering in the Global Generics Industry 2009: A guide to companies
Table of Contents Published: 2009/10 Published by: Espicom Business Intelligence
The operating environment for generic companies is changing rapidly as the industry matures and growth focuses on new market opportunities. ...

Oxygen Therapy
Table of Contents Published: 2009/10 Published by: Global Industry Analysts, Inc.
The global outlook series on Oxygen Therapy provides statistical anecdotes, market briefs, and concise summaries of research findings. The report offers an aerial view of the global oxygen therapy industry, identifies major short to medium term market cha ...

Pharmaceutical Speaker Programs - Measuring ROI and Communicating Value
Table of Contents Published: 2009/10 Published by: Cutting Edge Information
The ever-present regulatory scrutiny that the life science industry currently faces has not overlooked speaker events. Soaring healthcare costs and worries about the influence of drug companies on prescribing behavior bring any intersection of the two com ...

Drug Delivery Partnering Agreements in Pharma and Biotech
Table of Contents Published: 2009/10 Published by: CurrentPartnering, a division of Wildwood Ventures Limited
The Drug Delivery Partnering Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds leading healthcare companies. ...

Infectious Diseases Drugs Markets
Table of Contents Published: 2009/10 Published by: Trimark Publications
According to the World Health Organization (WHO), six infectious diseases--pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS--account for half of all premature deaths worldwide, killing mostly children and young adults. ...

Disposable Syringe Markets
Table of Contents Published: 2009/10 Published by: Trimark Publications
This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provid ...


<< Previous Page:   1   2   3   4   5   6   7   8   9   10   11   12   Next >>

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.